- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Toby Cosgrove, MD, Discusses Strategies for Bending the Cost Curve
Toby Cosgrove, MD, president and CEO, The Cleveland Clinic, says their organization has implemented a variety of strategies to bend the cost curve.
Toby Cosgrove, MD, president and CEO, The Cleveland Clinic, says their organization has implemented a variety of strategies to bend the cost curve. He suggests that healthcare organizations should serve as role models for what is required to improve health outcomes. Some initiatives they practice include banning smoking on campus and refusing to hire smokers. As well, they removed sugared drinks and fried foods from company cafeterias. They also offer exercise programs to employees.
“We’re concerned that one of the main drivers of cost in healthcare [are] patients' behaviors,” Dr Cosgrove says. “We know that obesity, sedentary life, and smoking are major drivers of chronic disease and cost.”
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
How Mirdametinib Improves QOL for People With NF1-Associated Plexiform Neurofibromas
March 18th 2025Christopher L. Moertel, MD, University of Minnesota, discusses the trial data that helped get mirdametinib approved and what providers can do to keep measuring quality of life (QOL) improvements.
Read More
For Neuromuscular Disease Community, an Era of Opportunities and Threats
March 17th 2025Robert Califf, MD, former commissioner of the FDA, delivered a keynote address at the 2025 Muscular Dystrophy Association Clinical & Scientific Conference that highlighted the enormous opportunities for progress in neuromuscular disease care amid a changing policy environment.
Read More
